Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_provenance.
- NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_assertion description "[In pancreatic cancer, 15/31 (48.4%) patients showed overexpression of SPARC (ratio tumor/normal >1) whereas in CPV only 1/8 (12.5%) exhibited SPARC overexpression and this difference was statistically significant (p<0.05, Mann-Whitney test).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_provenance.
- NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_assertion evidence source_evidence_literature NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_provenance.
- NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_assertion SIO_000772 16596217 NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_provenance.
- NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_assertion wasDerivedFrom befree-20140225 NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_provenance.
- NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_assertion wasGeneratedBy ECO_0000203 NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP203714.RADO1ASGMqyEdPp2NK88df2jiqx8oeU4gA6wwRxnKFLfI130_provenance.